Evidence map›Paper›PMID 31276024›Full record

ArticleTobacco regulatory science2017

A Novel Method for Evaluating the Acceptability of Substitutes for Cigarettes: The Experimental Tobacco Marketplace.

Bryan W Heckman, K Michael Cummings, Alexander A Hirsch, Amanda J Quisenberry, Ron Borland, Richard J O'Connor, Geoffrey T Fong, Warren K Bickel

Abstract read
In one paragraph

Article in Tobacco regulatory science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Development and Piloting Testing of an Experimental Tobacco and Nicotine Product Marketplace.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2020
    Article
  16. The Experimental Tobacco Marketplace: Demand and Substitutability as a Function of Cigarette Taxes and e-Liquid Subsidies.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2020
    Article
  17. Behavioral Outcomes of Nicotine Reduction in Current Adult Smokers.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2019
    Article
  18. Article
  19. Article
  20. Behavioral Economic Purchase Tasks to Estimate Demand for Novel Nicotine/tobacco Products and Prospectively Predict Future Use: Evidence From The Netherlands.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bryan W HeckmanDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC.
K Michael CummingsDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC.
Alexander A HirschDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC.
Amanda J QuisenberryHealth Behavior and Health Promotion, The Ohio State University, Columbus, OH, Charleston, SC.
Ron BorlandNigel Gray Fellowship Group, Cancer Council Victoria, Melbourne, AU.
Richard J O'ConnorDepartment of Health Behavior, Roswell Park Cancer Institute, Buffalo, NY.
Geoffrey T FongDepartment of Psychology, University of Waterloo, Waterloo, CA.
Warren K BickelVirginia Tech Carilion Research Institute, Virginia Tech, Roanoke, VA.

Funding

Project 4: Comprehension of Health Risks in More and Less Arousing Affe p240-275P50CA180908 · NCI · OHIO STATE UNIVERSITY · PI SHIELDS, PETER G., WEWERS, MARY ELLEN · 2013 to 2017
$18.9M
Variation in Cigarettes, Tobacco use Behaviors and Exposures in ITC CountriesP01CA138389 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI CUMMINGS, KENNETH MICHAEL · 2009 to 2013
$13.4M
Clinical Scientists Training Program in Addictions at MUSCK12DA031794 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Kevin M. Gray, AIMEE L MCRAE-CLARK · 2013 to 2026
$7.2M
Personalized Smoking Relapse Prevention Delivered in Real-Time via Just-in-time Adaptive InterventionsK23DA041616 · NIDA · MEHARRY MEDICAL COLLEGE · PI HECKMAN, BRYAN WAYNE · 2017 to 2021
$929k
NCI NIH HHS P01 CA138389NCI NIH HHS P50 CA180908NHLBI NIH HHS L30 HL130155NIDA NIH HHS K12 DA031794NIDA NIH HHS K23 DA041616
6 · The paper itself

Abstract

objectivesThe current study tests the substitutability of nicotine replacement therapy (NRT), electronic cigarettes (ECs), and very low nicotine cigarettes (VLNCs) in the context of an online experimental tobacco marketplace (ETM) that was designed to mimic the choices of smokers under 4 policy scenarios.

methodsDutch cigarette smokers (N = 840) completed an online survey in July 2015. The ETM was comprised of conventional cigarettes, VLNCs, ECs (disposable/cartridge/tank systems), and NRT (lozenges/patches/tabs). All participants completed a scenario in which conventional cigarettes were banned. To test additional policy scenarios participants were randomized to one of 3 experiments: 1) no VLNCs, 2) all products available, or 3) no ECs. Hypothetical weekly purchases were made when the cost for conventional cigarettes was ½ market price (MP), MP, 2x MP, and 4x MP. Substitutability was measured by the change in estimated consumption as cigarette prices increased.

resultsTank and cartridge ECs and VLNCs were stronger cigarette substitutes than disposable ECs and NRT products. Substitution of ECs and NRT for cigarettes was dampened when VLNCs were available.

conclusionsThe ETM offers a method to predict how smokers might respond to policies that alter the availability of potentially substitutable products available in the marketplace.

Indexed as

behavioral economicsdemande-cigarettesnicotine reductionprice

Identifiers

PMID31276024
PMCPMC6605101

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.